Novistra advices Max Neeman, a subsidiary of Max India, on its acquisition by JSS Medical Research Canada
New York, June 2015
Novistra Capital, a New York based boutique advisory, announced today that Max Neeman International, a subsidiary of Max India, was acquired by JSS Medical Research, Canada.

Max Neeman is a leading CRO in India with its head office in New Delhi, India. Additional regional offices are located in Ahmedabad, Bangalore, Chennai, Mumbai, and a US office in Raleigh, NC. The management team at Max Neeman will continue to remain with JSS and will assume new roles in the combined entity.

JSS Medical Research is the largest CRO in Montreal led by Dr. John Sampalis. The Company has recently made an acquisition in Latin America and continues to strengthen its presence around the world.